• Finnish healthcare system has reduced multiple sclerosis diagnosis time from ten to five months, enabling earlier treatment initiation and improved patient outcomes.
• Treatment protocols have shifted dramatically, with highly effective immunomodulating medications now being prescribed as first-line therapy instead of traditional moderate-efficacy drugs.
• Despite COVID-19 pandemic challenges, Finland maintained consistent MS diagnosis and treatment timelines, demonstrating resilient healthcare delivery.